In this podcast, Monica Aggarwal, MD, explains the lifestyle modifications that are key for the prevention of cardiovascular disease and how clinicians can encourage their patients to make the...
In this podcast, Peter Jones, MD, gives a preview of his presentation on the prevention of cardiovascular disease and the treatment of dyslipidemia, which will be presented at the Practical Updates in...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about treating patients with cardiovascular disease and diabetes—with a special focus on how to choose the appropriate novel...
In this podcast, Robert S. Rosenson, MD, from the Icahn School of Medicine at Mount Sinai in New York, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease...
In this commentary, a team from Johns Hopkins Medicine writes about their experiences creating and implementing a digital health platform and explains how apps can contribute to improving patients’ health.
...
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
In this editorial by Consultant Board Member Dr Michael Bloch, he reflects on a 1961 Consultant article about cardiovascular disease management and how it has affected him.
